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Abstract 
The aim of this study was to evaluate biocompati-
bility of multilevel composites based on bioresorbable 
poly(lactide-co-glycolide) (PGLA). Polymer matrix was 
modified with multidimensional (MD) short biopolymer 
fibers of calcium alginate (CA) containing bioactive 
ceramic nanoparticles (nanohydroxyapatite - HA or 
nanosilica - SiO2). The nanocomposite fibres present 
in the polymer samples influenced cells morphology, 
viability and secretory activity which was estimated 
using human osteoblasts cells (NHOst). The results 
indicate that biodegradable nanocomposite CA-HA/
PGLA improves biological properties of the basic 
biomaterial (PGLA) suggesting its potential application 
for bone tissue engineering.
Keywords: cells materials interaction, cells factors, 
composite, nanocomposite materials
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Introduction
Polymer-fiber composites are one of the main groups of 
materials used in the bone tissue regenerative medicine, 
which have better utilitarian properties than currently used 
implants [1-5]. One of the most promising approaches 
in modern medicine is make the most of regenerative 
potential of living organism. As a support for defected tis-
sue regeneration nanocomposite materials were applied. 
In comparison to classic (bio)materials nanocomposites 
show better mechanical and biological properties [6]. 
Interestingly, combination of two biocompatible resorbable 
polymer together with other bioactive materials e.g. fibers 
or powder [7] gives the possibility to obtain biocomposite 
materials with properties which mimic natural extracellular 
substance of the bone (structurally biomimetic). Moreover, 
this kind of multilevel composite materials (in macro level 
– fibres, in nano level - nanoparticles) can be formed as 
two- or three-dimensional materials (films, membranes 
or scaffolds) to create optimal conditions for multicellular 
culture for the bone regeneration. 
In the present work hybrid fibrous supports based on 
biodegradable co-polymer of glycolide and L-lactide (PGLA) 
containing nanocomposite calcium alginate fibres (CA) 
enriched with either nanometric hydroxyapatite (CAH) or 
nanometric silica (CAS) were prepared. The aim of ap-
plication of biopolymer fibres made of calcium alginate 
was the fabrication of biomimetic polymer-fibrous structure 
which simultaneously was a reservoir of bioactive particles. 
Nanocomposite fibres were comminuted to submicron and 
micron sizes and introduced into the PGLA polymer matrix. 
Preliminary studies showed that CAS/PGLA and CAH/PGLA 
hybrid materials were biocompatible and their surface prop-
erties positively influenced adhesion of bone cells. Potential 
site of implantation of the studied materials is bone tissue 
and thus their effect on morphology and secretory activity 
of osteoblasts, which are crucial cells for its development 
and rebuilding, was tested. 
Materials and Methods
Materials in the form of 2D supports (thin foils) were 
produced using the casting method. As matrix was used 
poly(lactide-co-glycolide) (PGLA, Sigma-Aldrich) which was 
dissolved in dichloromethane (CH2Cl2, POCh)  in 1:10 wt. 
ratio. As nanocomposites fibrous phases were used short 
biopolymer fibres (calcium alginate, FGM BioPolymers) 
modified by nanometric silica (5-10 nm, Sigma Aldrich) 
and nanometric hydroxyapatite (30-50 nm, Sigma-Aldrich). 
Nanocomposite fibres (calcium alginate with silica – named 
CAS and calcium alginate with hydroxyapatite – named 
CAH) were produce by wet method in Technical University 
of Lodz. Before the introduction into the matrix the nano-
composite fibres (CAS, CAH) were mechanically ground in a 
vibration ball mill. The final form of the modifier was a mixture 
of two fractions; short fibres, particles of the fibres and the 
nano-additive, which were products of the nanocomposite 
fibres fragmentation. The mean size of the fibres fragmen-
tation products (biopolymer particles, nanoadditives) was 
between 20 and 30 µm (optical microscope). The polymer 
– fibres nanocomposites (2 wt% of nanocomposite fibres) 
were prepared using a casting method. Characteristic of 
thin foils PGLA/CAS and PGLA/CAH were presented in 
previous study [8].
Cell cultures
NHOst osteoblast cells (Clonetic Normal Human Oste-
oblast Cell System, Lonza, USA) were cultured in 75-ml 
plastic bottles (Nunc, Denmark) in OGM culture medium 
(Lonza, USA) enriched with ascorbic acid (Lonza, USA), 
10% fetal bovine serum (Lonza, USA) and 100 U/ml peni-
cillin 10 UI/mL and 100 μg/mL streptomycin (Lonza, USA). 
Cells were cultured in the incubator HeraCell (ThermoSci-
entific, Germany) at 37°C and 5% of CO2. Every 3 days 
the cell cultures were passaged by trypsinization (0.25% 
solution of trypsin, Sigma-Aldrich, Germany). Before cell 
culture the biomaterial foils were washed in 70% ethanol 
and sterilized under UV lamp for 30 min from both sides and 
placed at the 24-well culture dishes (Nunc, Denmark). Cells 
(after 3 passages) were counted in Bürker’s hemocytometer, 
and seeded (1.5x104 cell/ml) in the 24-well culture plates 
(Nunc, Denmark) containing foils of the tested biomaterials. 
Pure PGLA foil was used as a control (CTR) material. Cells 
were cultured for 3 or 7 days. Subsequently, morphology of 
cells adhering to the biomaterials was observed using the 
inverted microscopy. Supernatants from cell cultures were 
collected and frozen at -20oC prior to cytotoxicity, protein 
and nitric oxide evaluation. 
3Cell morphology and viability
Cells were stained for 2 min with 0.01% acridine orange 
(Sigma-Aldrich, Germany) in PBS, washed with PBS, and 
observed using the fluorescent microscope (Olympus CX41, 
Japan).
Cytotoxicity assay
The loss of cell membrane integrity is reflected in the 
release of adenylate kinase AK, which can be detected 
using the firefly luciferase system (ToxiLight® BioAssay 
Kit, Lonza, Basel, Switzerland), a highly sensitive assay 
designed to measure cell membrane damage [9]. After 3 and 
7 days of osteoblast incubation on the tested biomaterials, 
5 μl of culture media was transferred to wells of a 384-well 
plate (Nunc, Denmark) and 25 μl of the Adenylate Kinase 
Detection Reagent (AKDR) were added per well. The plates 
were incubated for 5 min in the dark, and then luminescence 
was measured using the luminometer (PolarStar Omega) 
at 565 nm. Culture medium served as negative control, 
while cells treated with active AKDR reagent were used as 
positive control.
Nitrite/nitrate (NO) production
The total amount of NO (NO2- and NO3-) was measured 
as described previously [10]. Briefly, nitrate was reduced 
to nitrite by addition of nitrate reductase, FAD and NADPH 
(all from Sigma-Aldrich, Germany) and then NADPH was 
oxidized by lactate dehydrogenase in the presence of 
sodium pyruvate (both from Sigma-Aldrich, Germany). 
Finally, nitrite concentration in the samples was measured 
by the Griess reaction, by adding Griess reagents (0.1% 
naphthalethylenediamine dihydrochloride in H2O and 1% 
sulphanilamide in 5% concentrated H3PO4; 1:1 vol/vol) in a 
ratio 1:1 to samples and standards. Sodium nitrite solution 
was used as an internal control for the Griess assay and 
NaNO3 (both from Sigma-Aldrich, Germany) as controls for 
reduction step. The NO levels were measured at 540 nm 
with Expert Plus spectrophotometer (Asys Hitech, Eugen-
dorf, Austria).
FIG. 1. Morphology of NHOst osteoblasts cultured on a control material PGLA and on PGLA including nanoad-
ditives [CAS/PGLA or CAH/PGLA]. Morphology of cells was analyzed in fluorescence microscopy after 3 (left 
panel) and 7 days (right panel) of incubation. Analized materials: PGLA (A) CAS/PGLA (B), CAH/PGLA (C).
4 Protein production
Protein concentration in the supernatants collected 
from cell cultures was measured by the colorimetric BCA 
method as described previously [11]. Briefly, a mixture of 
copper (II) sulfate solution (CS, Sigma-Aldrich, Germany) 
and bicinchoninic acid solution (BCA; Sigma-Aldrich, Ger-
many) in a ratio of 1:50 was prepared. Subsequently 10 μl 
of each tested sample was transferred to wells of a 96-well 
plate and then 200 μl of the CS/BCA mixture was added. 
The plates were incubated for 30 minutes in the dark. The 
optical density was measured at 570 nm with Expert Plus 
spectrophotometer (Asys Hitach, Austria).
Statistics
The results were presented as mean values +/- the 
standard error (SEM). Statistical analyses were performed 
using the T-Tukey’s test. The statistical significance of dif-
ferences was set at p < 0.05.
Results and discussion
Disruptions of the cell functions, their adherence, pro-
liferation or secretory activity, may lead to delayed and/or 
incorrect integration of implanted biomaterial with recipient 
tissue. This can for example affect balance between bone 
formation and resorption reactions, which may then cause 
decrease of bone mass at the implantation site [12]. Although 
suitable for use in bone tissue regeneration physico-chemi-
cal properties of synthetic biodegradable polymers have 
been developed so far none of bioactive polymer culture 
medium does not satisfy the assumptions of the bone tis-
sue engineering [13]. Therefore, in the present work we 
focused on examining the functioning of NHOst osteoblasts 
in vitro on polymer-fibre composites containing silica and 
hydroxiapatite nanoparticles. These nanoparticles gradually 
released from matrix supposed to improve osteoinducive or 
osteoconductive properties of biomaterials. We studied cell 
morphology, viability, and their secretory activity. On day 3 
of culture the highest concentration of cells was observed 
on the surface of PGLA control material while fewer cells 
adhered to CAS/PGLA and CAHA/PGLA materials. Morphol-
ogy of cells adherent to all materials was similar, osteoblasts 
adopted spindle shape (FIG. 1A). On day 7 number of the 
cultured cells increased on all materials in comparison 
to day 3, though the highest number of adherent osteob-
lasts was still observed on the control PGLA (FIG. 1B). 
Reduced osteoblast adherence/proliferation on materials 
with nanoparticles may be associated with their higher 
roughness. It was observed previously that smooth PGLA 
surface facilitates cell adherence and proliferation, whereas 
a rougher surface e.g. of PGLA modified by fibres hampers 
both processes [14-15]. However, same authors [9] showed 
that in vivo nanoparticles can form an anchor site for bone 
cells and therefore facilitate integration of implant. Both on 
day 3 and day 7 of culture a level of adenylate kinase (AK) 
in supernatant from osteoblasts cultured on CAS/PGLA 
was comparable to AK level measured in supernatants 
from cells cultured on control PGLA material (FIG. 2A 
and 2B), while it was lower in supernatants collected from 
cell cultures containing CAH/PGLA (FIG. 2A and 2B). 
These results are consistent with results of experiments 
obtained by Nie and co-workers [16], which showed that 
PGLA encapsulated with hydroxyapatite reduced the cy-
totoxicity of this material. Probably higher cytotoxicity of 
PGLA in vitro is the result of acidic pH of its degradation 
products. PGLA is yet successfully used as a material for 
implantation thanks to different regulation of system acidity 
changes in vivo [14]. Present results suggest that addition 
of CAH reduced cytotoxicity of the initial PGLA material. 
Interestingly, osteoblasts cultured on this material released 
to supernatant lower amounts of proteins (on day 3 and 7, 
FIG. 4A, FIG. 4B) and nitric oxide (day 7, FIG. 3B) com-
pared to cells cultured on PGLA only. Nitric oxide (NO) is an 
important immune mediator with profound cytotoxic effects 
towards surrounding cells and tissues [17]. Consequently, 
NO serves as a good indicator of inflammation and should 
be monitored e.g. during the wound healing process [18]. 
Reduced secretion of proteins and NO by osteoblasts 
cultured on CAH/PGLA suggests that hydroxyapatite nano-
particles did not stimulate inflammatory reaction which can 
be a good predictor for the future in vivo studies. 
FIG. 3. Production/release of nitric oxide (NO) by 
NHOst osteoblasts cultured on PGLA and nano-
composites materials basing on PGLA. Cells were 
cultured on biomaterials either 3 (A) or 7 days (B). 
All results are shown as means±SE. * indicates 
values significantly different compared to the 
control by (p<0.05).
FIG. 2. Cytotoxic effect of control material PGLA 
and nanocomposites materials basing on PGLA 
on NHOst osteoblast. Cells were cultured on bio-
materials either 3 (A) or 7 days (B).
5
Conclusions
The investigations demonstrated that the produced com-
posite hybrid materials which were a multilevel composite 
consisting biopolymer fibers (CA) with nanoparticles (SiO2, 
HA) can be applied in regenerative medicine. We can con-
clude that the addition of nanohydroxyapatite in biopolymer 
fibres to PGLA had a positive effect on osteoblast viability 
and activity, but more detailed studies are necessary to 
clarify its influence on bone formation. 
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